Click for best price
Neglected Tropical Diseases Drugs Vaccine Market Size, Share 2024
| Market size in 2023 |
US$ 325.4 million
|
Forecast Market size by 2030 |
US$ 453.5 million
|
| Growth Rate |
CAGR of 4.8% |
Number of Pages |
114 Pages |
The global Neglected Tropical Diseases Drugs and Vaccine market was valued at US$ 325.4 million in 2023 and is projected to reach US$ 453.5 million by 2030, at a CAGR of 4.8% during the forecast period.
This research report provides a comprehensive analysis of the Neglected Tropical Diseases Drugs and Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Neglected Tropical Diseases Drugs and Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Neglected Tropical Diseases Drugs and Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Neglected Tropical Diseases Drugs and Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Neglected Tropical Diseases Drugs and Vaccine market presents opportunities for various stakeholders, including Drugs, Vaccines. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Neglected Tropical Diseases Drugs and Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The Neglected Tropical Diseases (NTDs) Drugs and Vaccine Market is driven by the pressing need to combat and eradicate diseases that predominantly affect marginalized and underserved populations in tropical regions. NTDs, which include diseases like malaria, dengue, and schistosomiasis, cause significant morbidity and mortality, making it imperative to develop treatments and vaccines. As global health initiatives and pharmaceutical companies focus on addressing NTDs, the demand for research, development, and access to effective drugs and vaccines continues to grow. However, a key challenge for this market is the need to overcome financial and regulatory hurdles that often hinder investment in NTD research and drug development. Ensuring equitable access to these treatments, addressing drug resistance, and overcoming logistic challenges in delivering vaccines to remote areas are ongoing obstacles. Additionally, the market faces competition from other health priorities and diseases, requiring sustained efforts to mobilize resources and global commitment to eliminate NTDs. Striking a balance between innovation, affordability, and accessibility while addressing the unique challenges of NTDs is crucial for the continued progress of the Neglected Tropical Diseases Drugs and Vaccine Market.
Key Features:
The research report on the Neglected Tropical Diseases Drugs and Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Neglected Tropical Diseases Drugs and Vaccine market.
Market Overview: The report provides a comprehensive overview of the Neglected Tropical Diseases Drugs and Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Malaria, Ebola), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Neglected Tropical Diseases Drugs and Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Neglected Tropical Diseases Drugs and Vaccine market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Neglected Tropical Diseases Drugs and Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Neglected Tropical Diseases Drugs and Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Neglected Tropical Diseases Drugs and Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Neglected Tropical Diseases Drugs and Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Neglected Tropical Diseases Drugs and Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Neglected Tropical Diseases Drugs and Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Neglected Tropical Diseases Drugs and Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Malaria
- Ebola
- Dengue
- Chagas
- Leishmaniasis
- Other
- Market segment by Application
- Drugs
- Vaccines
Global Neglected Tropical Diseases Drugs and Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Artecef BV
- GlaxoSmithKline
- AstraZeneca
- Novartis
- Sanofi-Aventis
- Ranbaxy Labs
- Lupin
- Macleods Pharmaceuticals
- Cipla
- Romark Laboratories
- Toyama Chemica
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neglected Tropical Diseases Drugs and Vaccine, market overview.
Chapter 2: Global Neglected Tropical Diseases Drugs and Vaccine market size in revenue.
Chapter 3: Detailed analysis of Neglected Tropical Diseases Drugs and Vaccine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neglected Tropical Diseases Drugs and Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Neglected Tropical Diseases Drugs and Vaccine Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 325.4 million
|
| Forecast Market size by 2030 |
US$ 453.5 million
|
| Growth Rate |
CAGR of 4.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
114 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Neglected Tropical Diseases Drugs and Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neglected Tropical Diseases Drugs and Vaccine Overall Market Size
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size: 2023 VS 2030
2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neglected Tropical Diseases Drugs and Vaccine Players in Global Market
3.2 Top Global Neglected Tropical Diseases Drugs and Vaccine Companies Ranked by Revenue
3.3 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Neglected Tropical Diseases Drugs and Vaccine Companies in Global Market, by Revenue in 2023
3.5 Global Companies Neglected Tropical Diseases Drugs and Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Players in Global Market
3.6.1 List of Global Tier 1 Neglected Tropical Diseases Drugs and Vaccine Companies
3.6.2 List of Global Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Market Size Markets, 2023 & 2030
4.1.2 Malaria
4.1.3 Ebola
4.1.4 Dengue
4.1.5 Chagas
4.1.6 Leishmaniasis
4.1.7 Other
4.2 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
4.2.1 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2024
4.2.2 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2025-2030
4.2.3 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Market Size, 2023 & 2030
5.1.2 Drugs
5.1.3 Vaccines
5.2 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
5.2.1 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2024
5.2.2 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2025-2030
5.2.3 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Market Size, 2023 & 2030
6.2 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
6.2.1 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2024
6.2.2 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2025-2030
6.2.3 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030
6.3.2 US Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.3.3 Canada Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.3.4 Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030
6.4.2 Germany Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.3 France Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.4 U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.5 Italy Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.6 Russia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.7 Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.4.8 Benelux Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030
6.5.2 China Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.5.3 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.5.4 South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.5.5 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.5.6 India Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030
6.6.2 Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.6.3 Argentina Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030
6.7.2 Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.7.3 Israel Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.7.4 Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
6.7.5 UAE Neglected Tropical Diseases Drugs and Vaccine Market Size, 2019-2030
7 Neglected Tropical Diseases Drugs and Vaccine Companies Profiles
7.1 Artecef BV
7.1.1 Artecef BV Company Summary
7.1.2 Artecef BV Business Overview
7.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.1.4 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.1.5 Artecef BV Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.2.4 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.3.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.4.4 Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 Sanofi-Aventis
7.5.1 Sanofi-Aventis Company Summary
7.5.2 Sanofi-Aventis Business Overview
7.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.5.4 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.5.5 Sanofi-Aventis Key News & Latest Developments
7.6 Ranbaxy Labs
7.6.1 Ranbaxy Labs Company Summary
7.6.2 Ranbaxy Labs Business Overview
7.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.6.4 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.6.5 Ranbaxy Labs Key News & Latest Developments
7.7 Lupin
7.7.1 Lupin Company Summary
7.7.2 Lupin Business Overview
7.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.7.4 Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.7.5 Lupin Key News & Latest Developments
7.8 Macleods Pharmaceuticals
7.8.1 Macleods Pharmaceuticals Company Summary
7.8.2 Macleods Pharmaceuticals Business Overview
7.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.8.4 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.8.5 Macleods Pharmaceuticals Key News & Latest Developments
7.9 Cipla
7.9.1 Cipla Company Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.9.4 Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.9.5 Cipla Key News & Latest Developments
7.10 Romark Laboratories
7.10.1 Romark Laboratories Company Summary
7.10.2 Romark Laboratories Business Overview
7.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.10.4 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.10.5 Romark Laboratories Key News & Latest Developments
7.11 Toyama Chemica
7.11.1 Toyama Chemica Company Summary
7.11.2 Toyama Chemica Business Overview
7.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
7.11.4 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2019-2024)
7.11.5 Toyama Chemica Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Neglected Tropical Diseases Drugs and Vaccine Market Opportunities & Trends in Global Market
Table 2. Neglected Tropical Diseases Drugs and Vaccine Market Drivers in Global Market
Table 3. Neglected Tropical Diseases Drugs and Vaccine Market Restraints in Global Market
Table 4. Key Players of Neglected Tropical Diseases Drugs and Vaccine in Global Market
Table 5. Top Neglected Tropical Diseases Drugs and Vaccine Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Companies, 2019-2024
Table 8. Global Companies Neglected Tropical Diseases Drugs and Vaccine Product Type
Table 9. List of Global Tier 1 Neglected Tropical Diseases Drugs and Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2025-2030
Table 30. Artecef BV Company Summary
Table 31. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 32. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 33. Artecef BV Key News & Latest Developments
Table 34. GlaxoSmithKline Company Summary
Table 35. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 36. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 37. GlaxoSmithKline Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 40. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 44. Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 45. Novartis Key News & Latest Developments
Table 46. Sanofi-Aventis Company Summary
Table 47. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 48. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 49. Sanofi-Aventis Key News & Latest Developments
Table 50. Ranbaxy Labs Company Summary
Table 51. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 52. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 53. Ranbaxy Labs Key News & Latest Developments
Table 54. Lupin Company Summary
Table 55. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 56. Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 57. Lupin Key News & Latest Developments
Table 58. Macleods Pharmaceuticals Company Summary
Table 59. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 60. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 61. Macleods Pharmaceuticals Key News & Latest Developments
Table 62. Cipla Company Summary
Table 63. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 64. Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 65. Cipla Key News & Latest Developments
Table 66. Romark Laboratories Company Summary
Table 67. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 68. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 69. Romark Laboratories Key News & Latest Developments
Table 70. Toyama Chemica Company Summary
Table 71. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 72. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn) & (2019-2024)
Table 73. Toyama Chemica Key News & Latest Developments
List of Figures
Figure 1. Neglected Tropical Diseases Drugs and Vaccine Segment by Type in 2023
Figure 2. Neglected Tropical Diseases Drugs and Vaccine Segment by Application in 2023
Figure 3. Global Neglected Tropical Diseases Drugs and Vaccine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2023
Figure 8. By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 9. By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 10. By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 12. By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 14. By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 15. By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 16. US Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 20. Germany Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 21. France Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 28. China Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 32. India Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 34. Brazil Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2019-2030
Figure 37. Turkey Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2019-2030
Figure 41. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
